BCIM yields 3.77% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, BCIM + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BCIM + MRK for your $10,000?
BCIM is a passively managed, collateralized commodity investment. The fund generally tracks an index of four industrial metals futures (copper, aluminum, zinc, and nickel)combined with collaterals in an attempt to enhance returns. The underlying index includes futures contracts with maturities of 1 to 3 months, rolled according to a fixed schedule. At each annual rebalancing, these futures positions are weighted by liquidity and production data, subject to diversification rules. The fund manages its commodity exposure through a wholly owned Cayman Islands subsidiarya common structure in the commodity ETF space. On another note, its cash collaterals are invested mainly in 3-month US Treasuries whose returns are calculated using the most recent weekly auction high rate. BCIM comes on the back of BCI and BCD, and rounds out abrdn K-1 Free ETF trust.
Full BCIM Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.